{"id":447031,"title":"Notice - Health Canada’s efforts to support innovative human therapeutic products to combat antimicrobial resistance (AMR)  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T13:25:35.377000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/programs/consultation-proposed-pathogens-interest-list/notice-efforts-combat-antimicrobial-resistance.html?wbdisable=false","snippet":"Notice - Health Canada's efforts to support innovative human therapeutic products to combat antimicrobial resistance (AMR) November 15, 2018 Our File number: 18-118504-727 The Issue Antimicrobial resistant (AMR) infections are becoming more frequent and increasingly difficult to…","rawSnapshotUrl":"/api/snapshots/raw/447031","browseUrl":"https://replay.healtharchive.ca/job-6/20260103132535/https://www.canada.ca/en/health-canada/programs/consultation-proposed-pathogens-interest-list/notice-efforts-combat-antimicrobial-resistance.html?wbdisable=false#ha_snapshot=447031","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}